Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Retrobulbar haematoma in the era of anticoagulants.

Berg BI, Flury E, Thieringer FM, Augello M, Savic M, Schötzau A, Kunz C, Goldblum D.

Injury. 2019 Aug 20. pii: S0020-1383(19)30507-8. doi: 10.1016/j.injury.2019.08.035. [Epub ahead of print]

PMID:
31519435
2.

N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.

Berger A, Brady NJ, Bareja R, Robinson B, Conteduca V, Augello MA, Puca L, Ahmed A, Dardenne E, Lu X, Hwang I, Bagadion AM, Sboner A, Elemento O, Paik J, Yu J, Barbieri CE, Dephoure N, Beltran H, Rickman DS.

J Clin Invest. 2019 Jul 1;130:3924-3940. doi: 10.1172/JCI127961.

3.

CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.

Augello MA, Liu D, Deonarine LD, Robinson BD, Huang D, Stelloo S, Blattner M, Doane AS, Wong EWP, Chen Y, Rubin MA, Beltran H, Elemento O, Bergman AM, Zwart W, Sboner A, Dephoure N, Barbieri CE.

Cancer Cell. 2019 May 13;35(5):817-819. doi: 10.1016/j.ccell.2019.04.012. No abstract available.

PMID:
31085180
4.

The Use of Finite Element Method Analysis for Modeling Different Osteotomy Patterns and Biomechanical Analysis of Craniosynostosis Correction.

Augello M, Maurer MM, Berg-Boerner I, Zeilhofer HF, Cattin P, Juergens P.

J Craniofac Surg. 2019 May 1. doi: 10.1097/SCS.0000000000005579. [Epub ahead of print]

PMID:
31058722
5.

CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.

Augello MA, Liu D, Deonarine LD, Robinson BD, Huang D, Stelloo S, Blattner M, Doane AS, Wong EWP, Chen Y, Rubin MA, Beltran H, Elemento O, Bergman AM, Zwart W, Sboner A, Dephoure N, Barbieri CE.

Cancer Cell. 2019 Apr 15;35(4):603-617.e8. doi: 10.1016/j.ccell.2019.03.001. Epub 2019 Mar 28. Erratum in: Cancer Cell. 2019 May 13;35(5):817-819.

PMID:
30930119
6.

Comparison of an Er: YAG laser osteotome versus a conventional drill for the use in osteo- odonto-keratoprosthesis (OOKP).

Berg BI, Peyer M, Kuske L, Augello M, Schötzau A, Steineck M, Deibel W, Mathys D, Jürgens P, Kunz C, Goldblum D.

Lasers Surg Med. 2019 Aug;51(6):531-537. doi: 10.1002/lsm.23053. Epub 2019 Jan 15.

PMID:
30645014
7.

An uncommon cause for a non-healing cutaneous fistula in the parotid gland area - A case report.

Rabufetti A, Augello M, Husner A, Ghazal G, Leiggener CS.

Ann Med Surg (Lond). 2018 Aug 18;33:36-39. doi: 10.1016/j.amsu.2018.08.007. eCollection 2018 Sep.

8.

Performing partial mandibular resection, fibula free flap reconstruction and midfacial osteotomies with a cold ablation and robot-guided Er:YAG laser osteotome (CARLO®) - A study on applicability and effectiveness in human cadavers.

Augello M, Baetscher C, Segesser M, Zeilhofer HF, Cattin P, Juergens P.

J Craniomaxillofac Surg. 2018 Oct;46(10):1850-1855. doi: 10.1016/j.jcms.2018.08.001. Epub 2018 Aug 9.

PMID:
30146105
9.

Review article: Common emergency department presenting complaints of prisoners: A systematic review.

Harel N, Moskovitch JT, Weiland TJ, Augello MR.

Emerg Med Australas. 2019 Apr;31(2):183-192. doi: 10.1111/1742-6723.13161. Epub 2018 Aug 17.

PMID:
30120822
10.

MAPK Reliance via Acquired CDK4/6 Inhibitor Resistance in Cancer.

de Leeuw R, McNair C, Schiewer MJ, Neupane NP, Brand LJ, Augello MA, Li Z, Cheng LC, Yoshida A, Courtney SM, Hazard ES, Hardiman G, Hussain MH, Diehl JA, Drake JM, Kelly WK, Knudsen KE.

Clin Cancer Res. 2018 Sep 1;24(17):4201-4214. doi: 10.1158/1078-0432.CCR-18-0410. Epub 2018 May 8.

11.

Comparative microstructural analysis of bone osteotomies after cutting by computer-assisted robot-guided laser osteotome and piezoelectric osteotome: an in vivo animal study.

Augello M, Deibel W, Nuss K, Cattin P, Jürgens P.

Lasers Med Sci. 2018 Sep;33(7):1471-1478. doi: 10.1007/s10103-018-2502-0. Epub 2018 Apr 13.

PMID:
29654421
12.

Survival in Out-of-hospital Rapid Sequence Intubation of Non-Traumatic Brain Pathologies.

Fouche PF, Jennings PA, Smith K, Boyle M, Blecher G, Knott J, Raji M, Rosengarten P, Augello MR, Bernard S.

Prehosp Emerg Care. 2017 Nov-Dec;21(6):700-708. doi: 10.1080/10903127.2017.1325952. Epub 2017 Jun 16.

PMID:
28622071
13.

Disappearance of Electrocardiographic Abnormalities Associated with the Arrhythmic Pattern of a Barlow Disease After Surgical Mitral Valve Repair.

Augello M, Lanzarini L.

Clin Pract. 2017 Apr 20;7(2):946. doi: 10.4081/cp.2017.946. eCollection 2017 Apr 6.

14.

Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.

Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A, Sailer V, Augello M, Puca L, Rosati R, McNary TJ, Churakova Y, Cheung C, Triscott J, Pisapia D, Rao R, Mosquera JM, Robinson B, Faltas BM, Emerling BE, Gadi VK, Bernard B, Elemento O, Beltran H, Demichelis F, Kemp CJ, Grandori C, Cantley LC, Rubin MA.

Cancer Discov. 2017 May;7(5):462-477. doi: 10.1158/2159-8290.CD-16-1154. Epub 2017 Mar 22.

15.

SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling.

Blattner M, Liu D, Robinson BD, Huang D, Poliakov A, Gao D, Nataraj S, Deonarine LD, Augello MA, Sailer V, Ponnala L, Ittmann M, Chinnaiyan AM, Sboner A, Chen Y, Rubin MA, Barbieri CE.

Cancer Cell. 2017 Mar 13;31(3):436-451. doi: 10.1016/j.ccell.2017.02.004.

16.

Cell cycle-coupled expansion of AR activity promotes cancer progression.

McNair C, Urbanucci A, Comstock CE, Augello MA, Goodwin JF, Launchbury R, Zhao SG, Schiewer MJ, Ertel A, Karnes J, Davicioni E, Wang L, Wang Q, Mills IG, Feng FY, Li W, Carroll JS, Knudsen KE.

Oncogene. 2017 Mar 23;36(12):1655-1668. doi: 10.1038/onc.2016.334. Epub 2016 Sep 26.

17.

Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ).

Berg BI, Mueller AA, Augello M, Berg S, Jaquiéry C.

Dent J (Basel). 2016 Sep 2;4(3). pii: E29. doi: 10.3390/dj4030029. Review.

18.

Consequence of the tumor-associated conversion to cyclin D1b.

Augello MA, Berman-Booty LD, Carr R 3rd, Yoshida A, Dean JL, Schiewer MJ, Feng FY, Tomlins SA, Gao E, Koch WJ, Benovic JL, Diehl JA, Knudsen KE.

EMBO Mol Med. 2015 May;7(5):628-47. doi: 10.15252/emmm.201404242.

19.

Two case reports with literature review of the EEC syndrome: Clinical presentation and management.

Augello M, Berg BI, Albert Müller A, Schwenzer-Zimmerer K.

Case Reports Plast Surg Hand Surg. 2015 Sep 24;2(3-4):63-6. doi: 10.3109/23320885.2015.1086273. eCollection 2015.

20.

AR function in promoting metastatic prostate cancer.

Augello MA, Den RB, Knudsen KE.

Cancer Metastasis Rev. 2014 Sep;33(2-3):399-411. doi: 10.1007/s10555-013-9471-3. Review.

21.

Targeting cell cycle and hormone receptor pathways in cancer.

Comstock CE, Augello MA, Goodwin JF, de Leeuw R, Schiewer MJ, Ostrander WF Jr, Burkhart RA, McClendon AK, McCue PA, Trabulsi EJ, Lallas CD, Gomella LG, Centenera MM, Brody JR, Butler LM, Tilley WD, Knudsen KE.

Oncogene. 2013 Nov 28;32(48):5481-91. doi: 10.1038/onc.2013.83. Epub 2013 May 27.

22.

Aberrant BAF57 signaling facilitates prometastatic phenotypes.

Balasubramaniam S, Comstock CE, Ertel A, Jeong KW, Stallcup MR, Addya S, McCue PA, Ostrander WF Jr, Augello MA, Knudsen KE.

Clin Cancer Res. 2013 May 15;19(10):2657-67. doi: 10.1158/1078-0432.CCR-12-3049. Epub 2013 Mar 14.

23.

Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.

Augello MA, Burd CJ, Birbe R, McNair C, Ertel A, Magee MS, Frigo DE, Wilder-Romans K, Shilkrut M, Han S, Jernigan DL, Dean JL, Fatatis A, McDonnell DP, Visakorpi T, Feng FY, Knudsen KE.

J Clin Invest. 2013 Jan;123(1):493-508. doi: 10.1172/JCI64750. Epub 2012 Dec 21.

24.

Dual roles of PARP-1 promote cancer growth and progression.

Schiewer MJ, Goodwin JF, Han S, Brenner JC, Augello MA, Dean JL, Liu F, Planck JL, Ravindranathan P, Chinnaiyan AM, McCue P, Gomella LG, Raj GV, Dicker AP, Brody JR, Pascal JM, Centenera MM, Butler LM, Tilley WD, Feng FY, Knudsen KE.

Cancer Discov. 2012 Dec;2(12):1134-49. doi: 10.1158/2159-8290.CD-12-0120. Epub 2012 Sep 19.

25.

FOXA1: master of steroid receptor function in cancer.

Augello MA, Hickey TE, Knudsen KE.

EMBO J. 2011 Sep 20;30(19):3885-94. doi: 10.1038/emboj.2011.340. Review.

26.

mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer.

Schiewer MJ, Den R, Hoang DT, Augello MA, Lawrence YR, Dicker AP, Knudsen KE.

Endocr Relat Cancer. 2012 Jan 9;19(1):1-12. doi: 10.1530/ERC-11-0072. Print 2012 Feb.

27.

Factors associated with failure to successfully complete a procedure during emergency department sedation.

Holdgate A, Taylor DM, Bell A, MacBean C, Huynh T, Thom O, Augello M, Millar R, Day R, Williams A, Ritchie P, Pasco J.

Emerg Med Australas. 2011 Aug;23(4):474-8. doi: 10.1111/j.1742-6723.2011.01420.x. Epub 2011 May 17.

PMID:
21824315
28.

Risk factors for sedation-related events during procedural sedation in the emergency department.

Taylor DM, Bell A, Holdgate A, MacBean C, Huynh T, Thom O, Augello M, Millar R, Day R, Williams A, Ritchie P, Pasco J.

Emerg Med Australas. 2011 Aug;23(4):466-73. doi: 10.1111/j.1742-6723.2011.01419.x. Epub 2011 May 17.

PMID:
21824314
29.

Procedural sedation practices in Australian Emergency Departments.

Bell A, Taylor DM, Holdgate A, MacBean C, Huynh T, Thom O, Augello M, Millar R, Day R, Williams A, Ritchie P, Pasco J.

Emerg Med Australas. 2011 Aug;23(4):458-65. doi: 10.1111/j.1742-6723.2011.01418.x. Epub 2011 May 17.

PMID:
21824313
30.

The AR dependent cell cycle: mechanisms and cancer relevance.

Schiewer MJ, Augello MA, Knudsen KE.

Mol Cell Endocrinol. 2012 Apr 16;352(1-2):34-45. doi: 10.1016/j.mce.2011.06.033. Epub 2011 Jul 12. Review.

31.

Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function.

Comstock CE, Augello MA, Schiewer MJ, Karch J, Burd CJ, Ertel A, Knudsen ES, Jessen WJ, Aronow BJ, Knudsen KE.

J Biol Chem. 2011 Mar 11;286(10):8117-27. doi: 10.1074/jbc.M110.170720. Epub 2011 Jan 5.

32.

Needle breakage during local anesthesia in the oral cavity--a retrospective of the last 50 years with guidelines for treatment and prevention.

Augello M, von Jackowski J, Grätz KW, Jacobsen C.

Clin Oral Investig. 2011 Feb;15(1):3-8. doi: 10.1007/s00784-010-0442-6. Epub 2010 Jul 13. Review.

33.

Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.

Olshavsky NA, Comstock CE, Schiewer MJ, Augello MA, Hyslop T, Sette C, Zhang J, Parysek LM, Knudsen KE.

Cancer Res. 2010 May 15;70(10):3975-84. doi: 10.1158/0008-5472.CAN-09-3468. Epub 2010 May 11.

34.

[Intraosseous anesthesia X-tip system in tooth extraction].

Augello M, Furrer T, Locher M.

Schweiz Monatsschr Zahnmed. 2009;119(8):809-17. French, German.

35.

Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer.

Comstock CE, Augello MA, Benito RP, Karch J, Tran TH, Utama FE, Tindall EA, Wang Y, Burd CJ, Groh EM, Hoang HN, Giles GG, Severi G, Hayes VM, Henderson BE, Le Marchand L, Kolonel LN, Haiman CA, Baffa R, Gomella LG, Knudsen ES, Rui H, Henshall SM, Sutherland RL, Knudsen KE.

Clin Cancer Res. 2009 Sep 1;15(17):5338-49. doi: 10.1158/1078-0432.CCR-08-2865. Epub 2009 Aug 25.

36.

Delayed versus immediate urethral catheterization following instillation of local anaesthetic gel in men: a randomized, controlled clinical trial.

Garbutt RB, McD Taylor D, Lee V, Augello MR.

Emerg Med Australas. 2008 Aug;20(4):328-32. doi: 10.1111/j.1742-6723.2008.01105.x.

PMID:
18782206
37.

[Chronic idiopathic intestinal pseudo-obstruction. Description of a case].

La Seta F, Buccellato A, Cabibbo L, Augello M, Gatto G, Vizzini GB.

Radiol Med. 1991 Mar;81(3):365-7. Italian. No abstract available.

PMID:
2014349
38.

Glyoxalase I polymorphism: gene frequencies in two Italian populations.

Scozzari R, Benincasa A, Augello M.

Hum Hered. 1981;31(4):208-10.

PMID:
7287011
39.

[Value and limitations of M-mode echocardiography in coronary disease. Study in 100 patients with angina pectoris].

Corallo S, Pezzano A, Castagnone M, Brusoni B, Augello M, Morandi G, Rovelli F.

G Ital Cardiol. 1979;9(8):806-16. Italian. No abstract available.

PMID:
549795
40.

[Effects of metoprolol acute administration on effort tolerance in patients affected by stable effort angina. Comparison with placebo and propranolol (author's transl)].

Ferratini M, Pirelli S, Salvadé P, Augello M, De Ponti C, Rovelli F.

G Ital Cardiol. 1979;9(12):1358-62. Italian. No abstract available.

PMID:
549784

Supplemental Content

Loading ...
Support Center